Colleen Johnson, M.S., D.A.B.T is a board-certified toxicologist who has been working with small- to mid-sized pharmaceuticals companies for more than 20 years. Her focus has primarily been in small molecule development for a broad range of indications. She is involved in providing toxicology expertise for all phases of development from early discovery to NDA and BLA applications. She received her undergraduate training at the University of California Santa Barbara and her graduate training at the University of Arizona. Colleen has overseen all aspects of the nonclinical development program on behalf of Flightpath Biosciences, Inc.